HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and Tenofovir.

PHASE4RecruitingINTERVENTIONAL

Enrollment

336

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions

Liver Fibrosis

Interventions

DRUG

PEG-Interferon Alfa, Tenofovir Disoproxil Fumarate

Combination therapy group was treated with PEG-interferon Alfa in addition to TDF monotherapy

DRUG

Tenofovir Disoproxil Fumarate

TDF monotherapy

Trial Locations (1)

RECRUITING

Third Affiliated Hospital of Sun Yat-sen University, Guangzhou

All Listed Sponsors

lead

Third Affiliated Hospital, Sun Yat-Sen University

OTHER